Maitreya Medicare (NSE:MAITREYA) Marketable Securities: ₹3.3 Mil (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAITREYA Maitreya Medicare Ltd NSE:MAITREYA
18 GF Score
Price ₹121.00
View Full Analysis

What is Maitreya Medicare Marketable Securities?

Maitreya Medicare NSE:MAITREYA +1.68% 18 Marketable Securities is ₹3.3 Mil as of Sep. 2023. GuruFocus rates NSE:MAITREYA with a GF Score™ of 18/100.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Maitreya Medicare's Marketable Securities for the quarter that ended in Sep. 2023 was ₹3.3 Mil.

Maitreya Medicare's annual Marketable Securities declined from Mar. 2021 (₹10.7 Mil) to Mar. 2022 (₹3.2 Mil) and declined from Mar. 2022 (₹3.2 Mil) to Mar. 2023 (₹2.3 Mil).

Maitreya Medicare  (NSE:MAITREYA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Maitreya Medicare Marketable Securities Related Terms

Maitreya Medicare Marketable Securities Historical Data

* Premium members only.

The historical data trend for Maitreya Medicare's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare Marketable Securities Chart

Maitreya Medicare Annual Data
Trend Mar21 Mar22 Mar23
Marketable Securities
10.74 3.22 2.29

Maitreya Medicare Semi-Annual Data
Mar21 Mar22 Mar23 Sep23
Marketable Securities 10.74 3.22 2.29 3.32
NSE:MAITREYA
18GF Score
Maitreya Medicare Ltd NSE:MAITREYA
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maitreya Medicare Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹3.3 Mil mean?
Maitreya Medicare (NSE:MAITREYA) has a Marketable Securities of ₹3.3 Mil as of Sep. 2023. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Maitreya Medicare and its competitors.
Is Maitreya Medicare's Marketable Securities too high?
Maitreya Medicare's current Marketable Securities is ₹3.3 Mil. Overall, Maitreya Medicare has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's Marketable Securities compare to HCA and DVA?
Maitreya Medicare's Marketable Securities of ₹3.3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Maitreya Medicare and its competitors. Maitreya Medicare's current Marketable Securities is ₹3.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Maitreya Medicare (NSE:MAITREYA) has a current Marketable Securities of ₹3.3 Mil. The current Marketable Securities is ₹3.3 Mil. Maitreya Medicare's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current Marketable Securities is ₹3.3 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maitreya Medicare Business Description

Address Nr. Someshwara Char Rasta, Udhana - Magdalla Road, Surat, GJ, IND, 395007
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
18GF Score

Get the complete analysis for NSE:MAITREYA

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹121.00
Price